Related references
Note: Only part of the references are listed.Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
Michele Schlich et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Takashi Nakamura et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Lipid nanoparticles fuse with cell membranes of immune cells at low temperatures leading to the loss of transfection activity
Takashi Nakamura et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Immunotherapy with NK cells: recent developments in gene modification open up new avenues
Lisa Marie Reindl et al.
ONCOIMMUNOLOGY (2020)
Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo
Yusuke Sato et al.
JOURNAL OF CONTROLLED RELEASE (2019)
The global pipeline of cell therapies for cancer
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
Rikito Endo et al.
SCIENTIFIC REPORTS (2019)
Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
Jianguang Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core
Takashi Nakamura et al.
MOLECULAR PHARMACEUTICS (2018)
Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells
Qing-Ming Wang et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
Sandro Matosevic
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Lipid Nanoparticle Systems for Enabling Gene Therapies
Pieter R. Cullis et al.
MOLECULAR THERAPY (2017)
Phase 1 clinical trial of adoptive immunotherapy using off-the-shelf activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Michael Boyiadzis et al.
CYTOTHERAPY (2017)
A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells
Shota Warashina et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells
Yusuke Sato et al.
MOLECULAR THERAPY (2016)
Natural Killer Cells for immunotherapy-Advantages of the NK-92 Cell Line over Blood NK Cells
Hans Klingemann et al.
FRONTIERS IN IMMUNOLOGY (2016)
Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
Takashi Nakamura et al.
SCIENTIFIC REPORTS (2016)
Intracellular delivery of nanomaterials: How to catch endosomal escape in the act
Thomas F. Martens et al.
NANO TODAY (2014)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery
Anthony S. Malamas et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Natural killer cell lines in tumor immunotherapy
Min Cheng et al.
Frontiers of Medicine (2012)
Signal Transducer and Activator of Transcription 3 (STAT3) and Suppressor of Cytokine Signaling (SOCS3) Balance Controls Cytotoxicity and IL-10 Expression in Decidual-Like Natural Killer Cell Line NK-92
Anne Braunschweig et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
Unexpected Role for Granzyme K in CD56bright NK Cell-Mediated Immunoregulation of Multiple Sclerosis
Wenzheng Jiang et al.
JOURNAL OF IMMUNOLOGY (2011)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akin Akinc et al.
NATURE BIOTECHNOLOGY (2008)
Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery
Xu-Li Wang et al.
BIOCONJUGATE CHEMISTRY (2007)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids
J Heyes et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92
G Maki et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Share Paper
